Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fresenius SE & Co. KGaA

http://www.fresenius.com

Latest From Fresenius SE & Co. KGaA

A Duchenne Breakthrough Awaits In 2023 - But Risks Remain For Sarepta And US FDA

The FDA and Sarepta have had a controversial history with the accelerated approvals of the firm’s earlier drugs for Duchenne muscular dystrophy – but the company’s investigational gene therapy, SRP-9001, now under a priority review, could be a genuine breakthrough.

Approvals Neurology

Financing Quarterly Statistics, Q3 2022

During Q3, biopharmas brought in an aggregate $18.1bn in financing and device company fundraising totaled $5.1bn; while in vitro diagnostic firms and research tools players raised $771m.

Deals Financing

Equillium Buys Metacrine For Its Cash, Will Outsource Lead Drug Candidate

Deal Snapshot: Equillium will gain $33m, extending its cash runway into 2024 and past several upcoming milestones, but it will seek a strategic partner for Metacrine’s stalled FXR agonist MET642.

Deals M & A

Minnetronix Launches Its Own Brain-Surgery Port; Mizuho Will Distribute

Minnetronix is launching MindsEye, the first expandable brain-access port for neurosurgery, through a partnership with Mizuho America. It is the first device that Minnetronix has brought to market on its own after 26 years as a contract service provider in the industry.

Neurology Surgery
See All

Company Information

  • Industry
  • Distributors
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
  • Services
  • Other Names / Subsidiaries
    • APP Pharmaceuticals, Inc.
    • Asia Renal Care Ltd.
    • Fresenius Kabi Pharmaceuticals Holding, Inc.
    • Fresenius Medical Care
    • Fresenius Medical Group AG
    • Vifor-Fresenius Medical Care Renal Pharma Ltd. (VFMCRP)
    • Xenios AG
UsernamePublicRestriction

Register